Mumbai, India's pharmaceutical powerhouse , hosts several significant players in the Carboplatin Active Pharmaceutical Ingredient (API) synthesis landscape. A number of companies , including Cipla, are known to offer Carboplatin API (CAS No: 41575-94-4) complying with stringent pharmaceutical sta